Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $22.3 billion, up 7.9% year-over-year, but lower than the Wall Street projection. Net earnings of $6.1 billion























